ALT, a liver enzyme indicative of liver function and the extent of hepatic damage, was elevated in MASLD/NAFLD owing to liver fat accumulation, suggesting its potential as a MASLD/NAFLD marker. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.